Anti-Human CD138/Syndecan-1 Rabbit Recombinant Antibody, PBS Only

CD138/Syndecan-1 Uni-rAb^TM Recombinant Antibody for FC

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

FC

Conjugate

Unconjugated

CloneNo.

240422C4

Cat no : 98051-1-PBS

Synonyms

CD138, 240422C4, syndecan, SYND1, SDC1

---

Validation Data Gallery

• 

  FC experiment of U266 using 98051-1-RR (same clone as 98051-1-PBS)

  1x10^6 U266 cells were surface stained with 0.25 ug Anti-Human SDC1,CD138 Rabbit Recombinant Antibody (98051-1-RR, Clone: 240422C4) and PE-Conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) (red), or 0.25 ug Isotype Control and PE-Conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) (blue). Cells were not fixed. This data was developed using the same antibody clone with 98051-1-PBS in a different storage buffer formulation.

• 

  Affinity and Kinetic Characterization of 98051-1-RR

  Biolayer interferometry (BLl) kinetic assays of 98051-1-RR against Human CD138/Syndecan-1 were performed. The affinity constant is 20.8 nM.

---

Product Information

The immunogen of 98051-1-PBS is CD138/Syndecan-1 Fusion Protein expressed in E. coli.

• Tested Reactivity: human
• Host / Isotype: Rabbit / IgG
• Class: Recombinant
• Type: Antibody
• Immunogen: Fusion Protein
• Full Name: syndecan 1
• Calculated Molecular Weight: 32.5 kDa
• GenBank Accession Number: BC008765
• Gene Symbol: CD138
• Gene ID (NCBI): 6382
• Conjugate: Unconjugated
• Form: Liquid
• Purification Method: Protein A purfication
• Storage Buffer: PBS Only
• Storage Conditions: Store at -80°C.

Background Information

CD138, also named as Syndecan-1 (SDC1), is an integral membrane protein. It participates in cell proliferation, cell migration and cell-matrix interactions via its receptor for extracellular matrix proteins. It is a heparan sulfate proteoglycan expressed on the surface of, and actively shed by, myeloma cells. Altered syndecan-1 expression has been detected in several different tumor types. CD138 was regarded as a useful marker for labeling normal and neoplastic plasma cells and plasmacytoid lymphomas.